Restoring apoptosis dysregulation using survivin inhibitor in nasopharyngeal cancer.
Junli ShiSoo Yee TanAndrea Zhe Ern LeeSiting ZhangSwarnalatha Lucky SasidharanBenjamin WongMin Han TanChwee Ming LimPublished in: Head & neck (2020)
YM-155 is a potential therapeutic agent for NPC through inhibiting survivin and restoring apoptosis dysregulation.